WEST CHESTER, Ohio--(BUSINESS WIRE)--Nov. 23, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced that it will
participate in the Piper Jaffray Healthcare Conference at the New York
Palace Hotel on Tuesday, December 1, 2009. David J. Drachman, President
and Chief Executive Officer, is scheduled to present at 4:00 p.m.
Eastern Time.
A live audio webcast and ...
Third Quarter Highlights
Non-GAAP operating loss improves 63% to a record $0.7 million
Record adjusted EBITDA of $0.7 million
Record non-GAAP net loss per share of $0.06
Year-to-date cash provided by operations of $0.3 million
European approval and initial launch of the AtriClip™ System
Settlement reserve established related to DOJ investigation
WEST CHESTER, Ohio--(BUSINESS WIRE)--Nov. 4, 2009-- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surg...
WEST CHESTER, Ohio--(BUSINESS WIRE)--Nov. 4, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced that it has reached a
tentative agreement, subject to completion and approval of a written
settlement agreement, with the Department of Justice (DOJ) to resolve
the issues raised in the DOJ’s investigation and the related qui tam
complaint regarding the marketing of the Co...
WEST CHESTER, Ohio--(BUSINESS WIRE)--Nov. 2, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced that it will
participate in the Canaccord Adams Cardiovascular Conference at Hotel
Nikko in San Francisco on Tuesday, November 10, 2009. David J. Drachman,
President and Chief Executive Officer, is scheduled to present at 3:30
p.m. Pacific Time.
About AtriCure, ...
WEST CHESTER, Ohio--(BUSINESS WIRE)--Oct. 16, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation products, will release its financial results
for the third quarter ended September 30, 2009 on Wednesday, November 4,
2009 and management will host a conference call at 10:00 a.m. Eastern
Time. A live webcast of the conference call will be available from the
investor relations page of AtriCure’s ...
WEST CHESTER, Ohio--(BUSINESS WIRE)--Oct. 6, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced CE Mark approval for
its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion System.
The AtriClip System is designed to safely and effectively exclude the
left atrial appendage and is being launched in Europe through a phased
approach during the fourth quarter.
...
WEST CHESTER, Ohio--(BUSINESS WIRE)--Sep. 18, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced that it will
participate in the following investor conferences during September and
October:
The UBS Global Life Sciences Conference at the Grand Hyatt New York
Hotel on Wednesday, September 23, 2009. Management is scheduled to
present at 12:30 p....
WEST CHESTER, Ohio--(BUSINESS WIRE)--Aug. 4, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced second quarter 2009
revenues of $13.8 million and an operating loss improvement of 43.4
percent to a record $1.0 million. For the first half of 2009, adjusted
EBITDA was a record $1.0 million, an improvement of $4.2 million over
the first half of 2008 adjusted EBITDA loss of $3....
WEST CHESTER, Ohio--(BUSINESS WIRE)--Jul. 28, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced that it will
participate in the following investor conferences during August:
The BMO Capital Markets Focus on Healthcare Conference at the
Millennium Broadway Hotel in New York on Wednesday, August 5, 2009.
David J. Drachman, President and Chief Executi...
WEST CHESTER, Ohio, Jul 21, 2009 (BUSINESS WIRE) -- AtriCure, Inc. (Nasdaq:ATRC), a medical device company and a leader in
cardiac surgical ablation products, will release its financial results
for the second quarter ended June 30, 2009 on Tuesday, August 4, 2009
and management will host a conference call at 10:00 a.m. Eastern Time. A
live webcast of the conference call will be available from the investor
relations page of AtriCure's corporate web site, ww...
Highlights
WEST CHESTER, Ohio--(BUSINESS WIRE)--May. 5, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems, today announced first quarter 2009
revenues of $13.7 million. Revenues grew 1.1% over the first quarter of
2008 and 13.3% over the fourth quarter of 2008.
“We are pleased with our first quarter results and remain confident
that, despite a challenging environment, AtriCure is...
WEST CHESTER, Ohio, Apr 09, 2009 (BUSINESS WIRE) -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation products, will release its financial results
for the first quarter ended March 31, 2009 on Tuesday, May 5, 2009 and
management will host a conference call at 10:00 a.m. Eastern Time. A
live webcast of the conference call will be available from the investor
relations page of AtriCure's corporate web site, www....
First Human Case Successfully Performed Using AtriCure's Cryo1 System
WEST CHESTER, Ohio--(BUSINESS WIRE)--Mar. 27, 2009--
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
surgical cardiac ablation, today announced that its new innovative
disposable cryoablation system, Cryo1, received 510(k) clearance from
the Food and Drug Administration, or FDA, for the cryosurgical treatment
of cardiac arrhythmias. Additionally, the first patient...
WEST CHESTER, Ohio--(BUSINESS WIRE)--Feb. 19, 2009--
AtriCure, Inc.:
Highlights
2008 revenues of $55.3 million – up 14% over 2007
2008 minimally invasive product revenues of $19.8 million – up 38%
2008 international revenues of $8.3 million – up 27%
25 patients enrolled to-date in EXCLUDE clinical trial
AtriCure, Inc. (Nasdaq: AT...
WEST CHESTER, Ohio, Feb 09, 2009 (BUSINESS WIRE) -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation products, will release its financial results
for the fourth quarter and year ended December 31, 2008 on Thursday,
February 19, 2009.
AtriCure will host a conference call at 10:00 a.m. Eastern Time on
Thursday, February 19, 2009 to discuss its fourth quarter and full year
2008 financial results. A live web ca...
